117 related articles for article (PubMed ID: 29058513)
21. Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
Soverini S; De Benedittis C; Polakova KM; Linhartova J; Castagnetti F; Gugliotta G; Papayannidis C; Mancini M; Klamova H; Salvucci M; Crugnola M; Iurlo A; Albano F; Russo D; Rosti G; Cavo M; Baccarani M; Martinelli G
Oncotarget; 2016 Apr; 7(16):21982-90. PubMed ID: 26980736
[TBL] [Abstract][Full Text] [Related]
22. Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.
de Smith AJ; Ojha J; Francis SS; Sanders E; Endicott AA; Hansen HM; Smirnov I; Termuhlen AM; Walsh KM; Metayer C; Wiemels JL
Oncotarget; 2016 Nov; 7(45):72733-72745. PubMed ID: 27683039
[TBL] [Abstract][Full Text] [Related]
23. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
[TBL] [Abstract][Full Text] [Related]
24. Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
Heikamp EB; Pui CH
J Pediatr; 2018 Dec; 203():14-24.e2. PubMed ID: 30213460
[No Abstract] [Full Text] [Related]
25. Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.
Ding LW; Sun QY; Tan KT; Chien W; Mayakonda A; Yeoh AEJ; Kawamata N; Nagata Y; Xiao JF; Loh XY; Lin DC; Garg M; Jiang YY; Xu L; Lim SL; Liu LZ; Madan V; Sanada M; Fernández LT; Hema Preethi SS; Lill M; Kantarjian HM; Kornblau SM; Miyano S; Liang DC; Ogawa S; Shih LY; Yang H; Koeffler HP
Cancer Res; 2017 Jan; 77(2):390-400. PubMed ID: 27872090
[TBL] [Abstract][Full Text] [Related]
26. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
[TBL] [Abstract][Full Text] [Related]
27. Novel mutations in the displacement loop of mitochondrial DNA are associated with acute lymphoblastic leukemia: a genetic sequencing study.
Yacoub HA; Mahmoud WM; El-Baz HA; Eid OM; ELfayoumi RI; Elhamidy SM; Mahmoud MM
Asian Pac J Cancer Prev; 2014; 15(21):9283-9. PubMed ID: 25422213
[TBL] [Abstract][Full Text] [Related]
28. SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data.
Medeiros JJF; Capo-Chichi JM; Shlush LI; Dick JE; Arruda A; Minden MD; Abelson S
Bioinformatics; 2022 Apr; 38(8):2088-2095. PubMed ID: 35150236
[TBL] [Abstract][Full Text] [Related]
29. Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.
Barnell EK; Waalkes A; Mosior MC; Penewit K; Cotto KC; Danos AM; Sheta LM; Campbell KM; Krysiak K; Rieke D; Spies NC; Skidmore ZL; Pritchard CC; Fehniger TA; Uppaluri R; Govindan R; Griffith M; Salipante SJ; Griffith OL
JCO Clin Cancer Inform; 2019 Oct; 3():1-12. PubMed ID: 31618044
[TBL] [Abstract][Full Text] [Related]
30. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.
Bellini A; Bernard V; Leroy Q; Rio Frio T; Pierron G; Combaret V; Lapouble E; Clement N; Rubie H; Thebaud E; Chastagner P; Defachelles AS; Bergeron C; Buchbinder N; Taque S; Auvrignon A; Valteau-Couanet D; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Clin Cancer Res; 2015 Nov; 21(21):4913-21. PubMed ID: 26059187
[TBL] [Abstract][Full Text] [Related]
31. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
32. Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment.
Berglund EC; Lindqvist CM; Hayat S; Övernäs E; Henriksson N; Nordlund J; Wahlberg P; Forestier E; Lönnerholm G; Syvänen AC
BMC Genomics; 2013 Dec; 14(1):856. PubMed ID: 24314227
[TBL] [Abstract][Full Text] [Related]
33. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
[TBL] [Abstract][Full Text] [Related]
34. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract][Full Text] [Related]
35. Ultrasensitive detection of acute myeloid leukemia minimal residual disease using single molecule molecular inversion probes.
Waalkes A; Penewit K; Wood BL; Wu D; Salipante SJ
Haematologica; 2017 Sep; 102(9):1549-1557. PubMed ID: 28572161
[TBL] [Abstract][Full Text] [Related]
36. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
Jacobson DR; Mills NE
Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
[TBL] [Abstract][Full Text] [Related]
37. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
[TBL] [Abstract][Full Text] [Related]
38. RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Perentesis JP; Bhatia S; Boyle E; Shao Y; Shu XO; Steinbuch M; Sather HN; Gaynon P; Kiffmeyer W; Envall-Fox J; Robison LL
Leukemia; 2004 Apr; 18(4):685-92. PubMed ID: 14990973
[TBL] [Abstract][Full Text] [Related]
39. A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells.
Spinella JF; Cassart P; Garnier N; Rousseau P; Drullion C; Richer C; Ouimet M; Saillour V; Healy J; Autexier C; Sinnett D
BMC Cancer; 2015 Sep; 15():621. PubMed ID: 26345285
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Sanchez R; Ayala R; Alonso RA; Martínez MP; Ribera J; García O; Sanchez-Pina J; Mercadal S; Montesinos P; Martino R; Barba P; González-Campos J; Barrios M; Lavilla E; Gil C; Bernal T; Escoda L; Abella E; Amigo ML; Moreno MJ; Bravo P; Guàrdia R; Hernández-Rivas JM; García-Guiñón A; Piernas S; Ribera JM; Martínez-López J
Ann Hematol; 2017 Jul; 96(7):1069-1075. PubMed ID: 28451802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
